Guselkumab for the Treatment of Patients with Moderate-to-severe Hidradenitis Suppurativa: A Phase 2 Randomized Study.
Alexa B KimballMaurizio PoddaAfsaneh AlaviMegan MillerYaung-Kaung ShenShu LiYan XuChenglong HanSteven FakharzadehYa-Wen YangSamuel DePrimoErnesto MunozYanqing ChenThierry PasseronKim A PappPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
gov: NCT03628924.